More SEC Filings
View Older Stories View Newer Stories-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 10-Q PG&E Corp For: Mar 31
-
Form 13F-HR Davidson Kahn Capital For: Mar 31
-
Form 13F-HR/A ICG Advisors, LLC For: Mar 31
-
Form D/A Nucleation Capital, LP
-
Form 8-K COMMUNITY HEALTH SYSTEMS For: Apr 22
-
Form ARS W&T OFFSHORE INC For: Dec 31
-
Form 6-K ROGERS COMMUNICATIONS For: Apr 22
-
Form 8-K Idaho Copper Corp For: Apr 17
-
Form 6-K/A NOVONIX Ltd For: Apr 23
-
Form D/A INVENTIA II A SERIES OF
-
Form DEFA14A W&T OFFSHORE INC
-
Form 13F-HR McBroom & Associates, For: Mar 31
-
Form 8-K NEWS CORP For: Apr 22
-
Form 13F-HR Lakewood Asset Managemen For: Mar 31
-
Form 13F-HR UG Investment Advisers For: Mar 31
-
Form 13F-HR WEBER CAPITAL MANAGEMENT For: Mar 31
-
Form 8-K SBC Medical Group Holdin For: Apr 19
-
Form S-3 Vireo Growth Inc.
-
Form 13F-HR VIEWPOINT INVESTMENT For: Mar 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 8-K PG&E Corp For: Apr 23
-
Form D MILESTONE SCIENTIFIC
-
Form D UP-10021 Fund I, a serie
-
Form 13F-HR McElhenny Sheffield Capi For: Mar 31
-
Form DEF 14A TUCOWS INC /PA/ For: Jun 02
-
Form D PE-1114 Fund I, a series
-
Form D HII Polymarket-06 a Seri
-
Form 424B2 BARCLAYS BANK PLC
-
Form S-1 Empower Annuity Insuranc
-
Form 13F-HR SFG Wealth Management, For: Mar 31
-
Form S-1/A Sky Acquisition Group
-
Form 425 ReserveOne Holdings, Filed by: ReserveOne Holdings, Inc.
-
Form S-1/A Sonoma Pharmaceuticals,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form POS AM Empower Annuity Insuranc
-
Form D/A VERTICAL OCEAN II A SERI
-
Form 13F-HR Clear Creek Financial For: Mar 31
-
Form 13F-HR Sentry LLC For: Mar 31
-
Form 8-K SHENANDOAH TELECOMMUNICA For: Apr 21
-
Form 13F-HR Aegis Wealth Management For: Mar 31
-
Form 13F-HR KG Capital Management For: Mar 31
-
Form D/A Fund FG-MLM, a series
-
Form D Latin-TR-0223 Fund I, a
-
Form 13F-HR Sterling Wealth Advisors For: Mar 31
-
Form 13F-HR TBH Global Asset Managem For: Mar 31
-
Form 13F-HR TICINO WEALTH For: Mar 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 13F-HR AJ Advisors, LLC For: Mar 31
-
Form 6-K Telix Pharmaceuticals For: Apr 22

